A 48-year-old woman with a T3N2M0 squamous cell carcinoma of the floor of mouth is planned for concurrent chemoradiotherapy. She has normal renal function and good performance status. Which chemotherapy regimen is the drug of choice for concurrent administration with radical radiotherapy?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.